Year Class/Forum Presentation Title
GBC 2020 Keynote & Plenary Keynote Speech Advanced Biopharmaceuticals: Oncolytic RNA viruses as cancer therapeutics
Hardev Pandha Director, Surrey Cancer Research Institute / Consultant Physician in Medical Oncology, University of Surrey
GBC 2020 Keynote & Plenary Keynote Speech Better health outcomes and a sustainable healthcare system: can we have both?
Joerg-Michael Rupp Head of International 7 Areas (i7) , F.Hoffmann-La Roche Ltd.
GBC 2020 Keynote & Plenary Keynote Speech Patient-centric regulatory approaches at the European Medicines Agency: 20 years of experience.
Agnès SAINT-RAYMOND Head of International Affairs Division, European Medicines Agency
GBC 2020 Keynote & Plenary Keynote Speech Accelerating the development of quality of biological medicines: COVID-19 treatments and vaccines
Fouad Atouf Head of Global Biologics, USPC (United States Pharmacopeial Convention)
GBC 2020 Keynote & Plenary Keynote Speech Direction and Future of K-Bio ventures
Seong-Jin Kim CEO, MedPacto, Inc.
GBC 2020 Keynote & Plenary Keynote Speech Creating value for patients through public private partnerships
Liz Henderson Regional Vice President - APAC, Merck Biopharma
GBC 2020 Keynote & Plenary Keynote Speech Special Video Interview : International efforts in response to COVID19: ways to cooperate between private and public sectors to overcome this public health crisis
Julie Louise Gerberding Executive Vice President, MSD
GBC 2020 Keynote & Plenary Keynote Speech New treatment paradigm shift: Gene Therapy
Robert Joseph Smith Senior Vice President, Global Gene Therapy Business, Rare Disease, Pfizer
GBC 2020 Keynote & Plenary Keynote Speech New Industrial Landscape in the Post COVID-19 Era
Jungjin Seo Chairman, Celltrion Group
GBC 2020 Vaccine Vaccine Forum Current Status of and Considerations for A Safe and Effective COVID-19 Vaccine Development
Woo Joo Kim Professor , Guro Hospital, Korea University College of Medicine
GBC 2020 Vaccine Vaccine Forum COVID 19 Vaccine Development
Jerome Hahn Kim Director General, International Vaccine Institute
GBC 2020 Vaccine Vaccine Forum Accelerating access to Covid-19 vaccines under a new normal
Jinho Shin Medical Officer, WHO
GBC 2020 Vaccine Vaccine Forum Coping with the pandemic threat: Development of regulatory requirements for COVID-19 vaccines in an emergency situation
Ralf Wagner Head of section for viral vaccines, Paul-Ehrlich-Institut
GBC 2020 Recombinant Protein Products Recombinant Protein Products Forum Global Trends, Needs and Limits on RWD/RWE
Ju-Young Shin Associate Professor, Sungkyunkwan University
GBC 2020 Recombinant Protein Products Recombinant Protein Products Forum Global Clinical Big Data Research Network based on Common Data Model: RWE-based Covid-19 Research cases
RAE WOONG PARK Professor, Ajou University School of Medicine